Douvlataniotis K, Titov A, Zeun J, Bilici M, Palashati H, Loh W, Rustad EH, Yang W, Tran TT, Lund-Johansen F, Bollineni RC, Kepple JD, Huth LP, Munthe LA, Boxaspen T, Schjesvold F, Waage A, Wagner DL, Bull KR, Hester J, Issa F, Giannakopoulou E, Olweus J (2026)
TCR T cells targeting IgA- and IgG-expressing multiple myeloma
Blood, 148 (16), 1984-1997
DOI 10.1182/blood.2025031897, PubMed 41770814

Forcados C, Köksal H, Scherer E, Abrantes R, Dillard P, Duarte HO, Josefsson S, Gomes C, de Montlaur C, Hellesøy HTZ, Dunkel R, Smeland EB, Myklebust JH, Reis CA, McCormack E, Gelebart P, Inderberg EM, Wälchli S (2026)
Reviving low-affinity glycan-targeting CAR with combinatorial design
Cell Rep Med, 103108 (in press)
DOI 10.1016/j.xcrm.2026.103108, PubMed 42849448

Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2026)
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Mol Ther (in press)
DOI 10.1016/j.ymthe.2026.09.027, PubMed 42800469